IRHOM2, A NEW TARGET FOR TREATMENT OF TNF-ALPHA-DEPENDENT PATHOLOGIES

$219,375FY2013Department of DefenseDOD

The Hospital For Special Surgery Fund, Inc.

Investigators

View source on USAspending →